Body composition and chemotherapy dose for gynecological cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how your body composition (amount of muscle and fat) affects chemotherapy dosing and treatment results for gynecological cancers. It aims to see if adjusting the dose based on your body type helps the treatment work better with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 20 and 80 years old.
- You need to be able to walk and care for yourself (with only a bit of help if any).
- You must have had an abdominal CT scan in the last 3 months, and the scan should have a clear image at the level of your belly button area.
- You must have a confirmed diagnosis of endometrial (lining of the uterus) or ovarian cancer.
- Your blood counts and liver and kidney function need to be within a certain range.
- You cannot have had another cancer in the last 2 years (except for some early-stage skin or breast cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether body fat and muscle (body composition) change how well certain chemotherapy works after surgery for early breast cancer. You may be considered if you are planned to receive docetaxel as adjuvant (after-surgery) chemotherapy and have recent CT scan images.
This study looks at how body composition (muscle and fat) changes in people with certain obesity-related cancers and whether these changes affect treatment outcomes. It may help doctors better understand how to support patients during treatment.
This study looks at how body composition (the amount of muscle and fat you have) relates to how accurately radiation therapy is aimed during treatment. By understanding this, doctors may improve treatment precision and reduce side effects.
This trial tests a special exercise program during chemotherapy before surgery. It may help patients with certain gynecologic cancers get stronger and better prepared for treatment.
This study tests whether a personalized dietary plan can help manage side effects and improve well-being in women with advanced breast or gynecologic cancer who are receiving antibody-drug conjugate (ADC) therapy. ADCs are a type of targeted cancer treatment that delivers chemotherapy directly to cancer cells.
This trial uses advanced imaging (ultrasound and CT) plus a blood test to predict how well your stomach cancer will respond to chemotherapy given before surgery. The goal is to personalize your treatment and improve outcomes.
Hear when a new Search MeSH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.